Andrew H. Galligan
Andrew H. Galligan has served on our board of directors since December 2014. Mr. Galligan held the top financial executive position at several medical device companies including, Nevro Corp., a medical devices company, where he has worked as its Chief Financial Officer from May 2010 through July 2020. Previously, he served as Ooma’s Chief Financial Officer from February 2009 to May 2010, and as a consultant for Ooma from September 2010 to December 2014. From 2007 to 2008, Mr. Galligan served as CFO of Reliant Technologies, Inc., a medical device company (later acquired by Solta Medical, Inc.). Mr. Galligan has also held top financial executive position at several other medical device companies and began his career in various financial positions at KPMG and Raychem Corp. Mr. Galligan was previously a director of diaDexus, Inc., which develops and commercializes diagnostic products for cardiovascular diseases, from 2010 through 2015. Mr. Galligan received a B.B.S. in Business and Finance from Trinity College, Dublin University (Ireland) and is also a Fellow of the Institute of Chartered Accountants in Ireland.
Our board of directors believes that Mr. Galligan’s financial expertise, including his several years of experience as chief financial officer and financial consultant of publicly traded and privately held companies, brings financial and accounting knowledge to our board and qualifies him to serve as the chairperson of our Audit Committee and as one of our directors.